There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Bicara Therapeutics Inc. (BCAX – Research Report) and HUTCHMED (HCM – Research Report) with bullish...
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc.
/CNW/ -- USA News Group News Commentary – The FDA's unprecedented wave of Breakthrough Therapy Designations through August has accelerated development...
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 19th:Century Aluminum CENX: This company which is engaged in the production of primary aluminum...
HUTCHMED announces Breakthrough Therapy Designation in China for ORPATHYS® and TAGRISSO® combination for advanced lung cancer.Quiver AI SummaryHUTCHMED has received Breakthrough Therapy Designation from...
HUTCHMED and Innovent announced conditional approval for fruquintinib plus sintilimab combination therapy for advanced endometrial cancer in China.Quiver AI SummaryHUTCHMED and Innovent Biologics have...
HUTCHMED announces ORPATHYS® will remain on China's National Reimbursement Drug List following contract renewal with NHSA.Quiver AI SummaryHUTCHMED (China) Limited announced that ORPATHYS® (savolitinib)...
HUTCHMED announces FRUZAQLA® launch in Japan for metastatic colorectal cancer after regulatory approval and milestone payment from Takeda.Quiver AI SummaryHUTCHMED has announced the approval and launch...
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:ABBV),(NASDAQ:BGNE),(NASDAQ:HCM),(NASDAQ:ELVN) EQNX::TICKER_END
/CNW/ -- USA News Group News Commentary – While some forms of cancer are seeing death rates fall, the world is witnessing a global surge in cancers among...